Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity

ABSTRACTTick-borne encephalitis virus (TBEV) infection may cause acute central nervous system inflammation varying in clinical manifestations and severity. A possible correlation of TBEV-specific antibody and cell-mediated immune responses, shortly after infection, with clinical manifestations, seve...

Full description

Bibliographic Details
Main Authors: Amare Aregay, Jan Slunečko, Petra Bogovic, Miša Korva, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Imke Steffen, Franc Strle, Tatjana Avšič-Županc, Albert D.M.E. Osterhaus, Guus F. Rimmelzwaan
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2024.2317909
_version_ 1797300509968695296
author Amare Aregay
Jan Slunečko
Petra Bogovic
Miša Korva
Katarina Resman Rus
Nataša Knap
Jana Beicht
Mareike Kubinski
Giulietta Saletti
Imke Steffen
Franc Strle
Tatjana Avšič-Županc
Albert D.M.E. Osterhaus
Guus F. Rimmelzwaan
author_facet Amare Aregay
Jan Slunečko
Petra Bogovic
Miša Korva
Katarina Resman Rus
Nataša Knap
Jana Beicht
Mareike Kubinski
Giulietta Saletti
Imke Steffen
Franc Strle
Tatjana Avšič-Županc
Albert D.M.E. Osterhaus
Guus F. Rimmelzwaan
author_sort Amare Aregay
collection DOAJ
description ABSTRACTTick-borne encephalitis virus (TBEV) infection may cause acute central nervous system inflammation varying in clinical manifestations and severity. A possible correlation of TBEV-specific antibody and cell-mediated immune responses, shortly after infection, with clinical manifestations, severity and long-term outcome has been poorly investigated. In a cohort of thirty early tick-borne encephalitis (TBE) patients, we assessed the magnitude, specificity and functional properties of TBEV-specific T-cell and antibody responses. These responses early during disease were assessed in view of clinical manifestations, severity and long-term outcome. TBEV-specific T-cell responses to C, E, NS1, and NS5 proteins were significantly lower in patients with severe acute illness than in patients with mild TBE. Lower T-cell responses to E, NS1, and NS5 proteins also correlated with the development of meningoencephalomyelitis. Virus-specific antibody titres early after infection did not correlate with disease severity, clinical manifestations, or long-term outcome in this study, possibly due to the small number of patients of which matching serum and peripheral blood mononuclear cells were available. The findings suggest that virus-specific T cells afford a certain degree of protection against the development of severe TBEV-induced disease.
first_indexed 2024-03-07T23:08:11Z
format Article
id doaj.art-8322d2c58d7a4e8190e93eb9a95a774a
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-03-07T23:08:11Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-8322d2c58d7a4e8190e93eb9a95a774a2024-02-21T20:49:12ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512024-12-0113110.1080/22221751.2024.2317909Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severityAmare Aregay0Jan Slunečko1Petra Bogovic2Miša Korva3Katarina Resman Rus4Nataša Knap5Jana Beicht6Mareike Kubinski7Giulietta Saletti8Imke Steffen9Franc Strle10Tatjana Avšič-Županc11Albert D.M.E. Osterhaus12Guus F. Rimmelzwaan13Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Foundation, Hannover, GermanyFaculty of Medicine, Institute for Microbiology and Immunology, University of Ljubljana, Ljubljana, SloveniaDepartment of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, SloveniaFaculty of Medicine, Institute for Microbiology and Immunology, University of Ljubljana, Ljubljana, SloveniaFaculty of Medicine, Institute for Microbiology and Immunology, University of Ljubljana, Ljubljana, SloveniaFaculty of Medicine, Institute for Microbiology and Immunology, University of Ljubljana, Ljubljana, SloveniaResearch Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Foundation, Hannover, GermanyResearch Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Foundation, Hannover, GermanyResearch Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Foundation, Hannover, GermanyResearch Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Foundation, Hannover, GermanyDepartment of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, SloveniaFaculty of Medicine, Institute for Microbiology and Immunology, University of Ljubljana, Ljubljana, SloveniaResearch Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Foundation, Hannover, GermanyResearch Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Foundation, Hannover, GermanyABSTRACTTick-borne encephalitis virus (TBEV) infection may cause acute central nervous system inflammation varying in clinical manifestations and severity. A possible correlation of TBEV-specific antibody and cell-mediated immune responses, shortly after infection, with clinical manifestations, severity and long-term outcome has been poorly investigated. In a cohort of thirty early tick-borne encephalitis (TBE) patients, we assessed the magnitude, specificity and functional properties of TBEV-specific T-cell and antibody responses. These responses early during disease were assessed in view of clinical manifestations, severity and long-term outcome. TBEV-specific T-cell responses to C, E, NS1, and NS5 proteins were significantly lower in patients with severe acute illness than in patients with mild TBE. Lower T-cell responses to E, NS1, and NS5 proteins also correlated with the development of meningoencephalomyelitis. Virus-specific antibody titres early after infection did not correlate with disease severity, clinical manifestations, or long-term outcome in this study, possibly due to the small number of patients of which matching serum and peripheral blood mononuclear cells were available. The findings suggest that virus-specific T cells afford a certain degree of protection against the development of severe TBEV-induced disease.https://www.tandfonline.com/doi/10.1080/22221751.2024.2317909TBEV; Tick-Borne Encephalitis (TBE); TBEV-specific T-cells; disease severity; outcome
spellingShingle Amare Aregay
Jan Slunečko
Petra Bogovic
Miša Korva
Katarina Resman Rus
Nataša Knap
Jana Beicht
Mareike Kubinski
Giulietta Saletti
Imke Steffen
Franc Strle
Tatjana Avšič-Županc
Albert D.M.E. Osterhaus
Guus F. Rimmelzwaan
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity
Emerging Microbes and Infections
TBEV; Tick-Borne Encephalitis (TBE); TBEV-specific T-cells; disease severity; outcome
title Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity
title_full Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity
title_fullStr Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity
title_full_unstemmed Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity
title_short Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity
title_sort poor virus specific t cell responses early after tick borne encephalitis virus infection correlate with disease severity
topic TBEV; Tick-Borne Encephalitis (TBE); TBEV-specific T-cells; disease severity; outcome
url https://www.tandfonline.com/doi/10.1080/22221751.2024.2317909
work_keys_str_mv AT amarearegay poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT janslunecko poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT petrabogovic poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT misakorva poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT katarinaresmanrus poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT natasaknap poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT janabeicht poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT mareikekubinski poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT giuliettasaletti poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT imkesteffen poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT francstrle poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT tatjanaavsiczupanc poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT albertdmeosterhaus poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity
AT guusfrimmelzwaan poorvirusspecifictcellresponsesearlyaftertickborneencephalitisvirusinfectioncorrelatewithdiseaseseverity